Medical Device Contract Sales Organizations (CSO) Market Companies, Size and Trends 2026-2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Device Contract Sales Organizations Market

5.1. COVID-19 Landscape: Medical Device Contract Sales Organizations Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Device Contract Sales Organizations Market, By Service Type

8.1. Medical Device Contract Sales Organizations Market, by Service Type

8.1.1. Personal/Direct Commercial Promotion

8.1.1.1. Market Revenue and Forecast

8.1.2. Non-Personal/Indirect Commercial Support

8.1.2.1. Market Revenue and Forecast

Chapter 9. Global Medical Device Contract Sales Organizations Market, By Personal/Direct Commercial Promotion

9.1. Medical Device Contract Sales Organizations Market, by Personal/Direct Commercial Promotion

9.1.1. Field Sales & Sales Force Outsourcing

9.1.1.1. Market Revenue and Forecast

9.1.2. Key & Strategic Account Management

9.1.2.1. Market Revenue and Forecast

9.1.3. Clinical & Technical Sales Support

9.1.3.1. Market Revenue and Forecast

9.1.4. Inside & Remote Sales

9.1.4.1. Market Revenue and Forecast

Chapter 10. Global Medical Device Contract Sales Organizations Market, By Non-Personal/Indirect Commercial Support

10.1. Medical Device Contract Sales Organizations Market, by Non-Personal/Indirect Commercial Support

10.1.1. Sales Training & Product Education

10.1.1.1. Market Revenue and Forecast

10.1.2. Channel & Distributor Support

10.1.2.1. Market Revenue and Forecast

10.1.3. Sales Operations & Analytics

10.1.3.1. Market Revenue and Forecast

10.1.4. Commercial Intelligence

10.1.4.1. Market Revenue and Forecast

10.1.5. Other Support Services

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Medical Device Contract Sales Organizations Market, By Therapeutic Area

11.1. Medical Device Contract Sales Organizations Market, by Therapeutic Area

11.1.1. Cardiovascular

11.1.1.1. Market Revenue and Forecast

11.1.2. Orthopedics

11.1.2.1. Market Revenue and Forecast

11.1.3. Neurology

11.1.3.1. Market Revenue and Forecast

11.1.4. Oncology

11.1.4.1. Market Revenue and Forecast

11.1.5. Diabetes & Metabolic Disorders

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Medical Device Contract Sales Organizations Market, By End User

12.1. Medical Device Contract Sales Organizations Market, by End User

12.1.1. Large Medical Device Companies

12.1.1.1. Market Revenue and Forecast

12.1.2. Mid-Sized Medical Device Companies

12.1.2.1. Market Revenue and Forecast

12.1.3. Small & Emerging Medical Device Companies

12.1.3.1. Market Revenue and Forecast

Chapter 13. Global Medical Device Contract Sales Organizations Market, By Engagement Model

13.1. Medical Device Contract Sales Organizations Market, by Engagement Model

13.1.1. Dedicated Sales Teams

13.1.1.1. Market Revenue and Forecast

13.1.2. Shared Sales Teams

13.1.2.1. Market Revenue and Forecast

13.1.3. Flexible/On-Demand Teams

13.1.3.1. Market Revenue and Forecast

13.1.4. Project-Based Engagements

13.1.4.1. Market Revenue and Forecast

13.1.5. Performance-Based Engagements

13.1.5.1. Market Revenue and Forecast

Chapter 14. Global Medical Device Contract Sales Organizations Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Service Type

14.1.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.1.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.1.4. Market Revenue and Forecast, by Therapeutic Area

14.1.5. Market Revenue and Forecast, by End User

14.1.6. Market Revenue and Forecast, by Engagement Model

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Service Type

14.1.7.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.1.7.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.1.7.4. Market Revenue and Forecast, by Therapeutic Area

14.1.8. Market Revenue and Forecast, by End User

14.1.8.1. Market Revenue and Forecast, by Engagement Model

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Service Type

14.1.9.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.1.9.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.1.9.4. Market Revenue and Forecast, by Therapeutic Area

14.1.10. Market Revenue and Forecast, by End User

14.1.11. Market Revenue and Forecast, by Engagement Model

14.2. Europe

14.2.1. Market Revenue and Forecast, by Service Type

14.2.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.2.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.2.4. Market Revenue and Forecast, by Therapeutic Area

14.2.5. Market Revenue and Forecast, by End User

14.2.6. Market Revenue and Forecast, by Engagement Model

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Service Type

14.2.8.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.2.8.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.2.9. Market Revenue and Forecast, by Therapeutic Area

14.2.10. Market Revenue and Forecast, by End User

14.2.10.1. Market Revenue and Forecast, by Engagement Model

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Service Type

14.2.11.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.2.11.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.2.12. Market Revenue and Forecast, by Therapeutic Area

14.2.13. Market Revenue and Forecast, by End User

14.2.14. Market Revenue and Forecast, by Engagement Model

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Service Type

14.2.15.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.2.15.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.2.15.4. Market Revenue and Forecast, by Therapeutic Area

14.2.16. Market Revenue and Forecast, by End User

14.2.16.1. Market Revenue and Forecast, by Engagement Model

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Service Type

14.2.17.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.2.17.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.2.17.4. Market Revenue and Forecast, by Therapeutic Area

14.2.18. Market Revenue and Forecast, by End User

14.2.18.1. Market Revenue and Forecast, by Engagement Model

14.3. APAC

14.3.1. Market Revenue and Forecast, by Service Type

14.3.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.3.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.3.4. Market Revenue and Forecast, by Therapeutic Area

14.3.5. Market Revenue and Forecast, by End User

14.3.6. Market Revenue and Forecast, by Engagement Model

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Service Type

14.3.7.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.3.7.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.3.7.4. Market Revenue and Forecast, by Therapeutic Area

14.3.8. Market Revenue and Forecast, by End User

14.3.9. Market Revenue and Forecast, by Engagement Model

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Service Type

14.3.10.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.3.10.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.3.10.4. Market Revenue and Forecast, by Therapeutic Area

14.3.11. Market Revenue and Forecast, by End User

14.3.11.1. Market Revenue and Forecast, by Engagement Model

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Service Type

14.3.12.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.3.12.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.3.12.4. Market Revenue and Forecast, by Therapeutic Area

14.3.12.5. Market Revenue and Forecast, by End User

14.3.12.6. Market Revenue and Forecast, by Engagement Model

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Service Type

14.3.13.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.3.13.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.3.13.4. Market Revenue and Forecast, by Therapeutic Area

14.3.13.5. Market Revenue and Forecast, by End User

14.3.13.6. Market Revenue and Forecast, by Engagement Model

14.4. MEA

14.4.1. Market Revenue and Forecast, by Service Type

14.4.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.4.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.4.4. Market Revenue and Forecast, by Therapeutic Area

14.4.5. Market Revenue and Forecast, by End User

14.4.6. Market Revenue and Forecast, by Engagement Model

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Service Type

14.4.7.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.4.7.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.4.7.4. Market Revenue and Forecast, by Therapeutic Area

14.4.8. Market Revenue and Forecast, by End User

14.4.9. Market Revenue and Forecast, by Engagement Model

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Service Type

14.4.10.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.4.10.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.4.10.4. Market Revenue and Forecast, by Therapeutic Area

14.4.11. Market Revenue and Forecast, by End User

14.4.12. Market Revenue and Forecast, by Engagement Model

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Service Type

14.4.13.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.4.13.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.4.13.4. Market Revenue and Forecast, by Therapeutic Area

14.4.13.5. Market Revenue and Forecast, by End User

14.4.13.6. Market Revenue and Forecast, by Engagement Model

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Service Type

14.4.14.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.4.14.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.4.14.4. Market Revenue and Forecast, by Therapeutic Area

14.4.14.5. Market Revenue and Forecast, by End User

14.4.14.6. Market Revenue and Forecast, by Engagement Model

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Service Type

14.5.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.5.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.5.4. Market Revenue and Forecast, by Therapeutic Area

14.5.5. Market Revenue and Forecast, by End User

14.5.6. Market Revenue and Forecast, by Engagement Model

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Service Type

14.5.7.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.5.7.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.5.7.4. Market Revenue and Forecast, by Therapeutic Area

14.5.8. Market Revenue and Forecast, by End User

14.5.8.1. Market Revenue and Forecast, by Engagement Model

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Service Type

14.5.9.2. Market Revenue and Forecast, by Personal/Direct Commercial Promotion

14.5.9.3. Market Revenue and Forecast, by Non-Personal/Indirect Commercial Support

14.5.9.4. Market Revenue and Forecast, by Therapeutic Area

14.5.9.5. Market Revenue and Forecast, by End User

14.5.9.6. Market Revenue and Forecast, by Engagement Model

Chapter 15. Company Profiles

15.1. IQVIA

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Inizio

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. EVERSANA

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Amplity

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Abbott

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Abbott

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Abbott

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Abbott

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Abbott

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Abbott

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : A medical device contract sales organization is an organization that is contracted by medical device manufacturers to sell medical devices and/or commercial services. It can act as a sales representative for products, assist with product launches, and increase product distribution for manufacturers.

Answer : They involve field sales, clinical sales, product promotion, account management, market development, sales force deployment, training, customer engagement, and commercial support. The scope depends on the product and market needs of the manufacturer.

Answer : The rising pressure on commercial costs, the increasing specialist nature of medical devices, quicker product releases, new markets, and manufacturers' preference for flexible sales-force models are all contributing to this.